Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mucormycosis in Indian COVID-19 Patients: Insight into Its Patho-Genesis, Clinical Manifestation, and Management Strategies.
Sahu RK, Salem-Bekhit MM, Bhattacharjee B, Almoshari Y, Ikbal AMA, Alshamrani M, Bharali A, Salawi A, Widyowati R, Alshammari A, Elbagory I. Sahu RK, et al. Among authors: bhattacharjee b. Antibiotics (Basel). 2021 Sep 6;10(9):1079. doi: 10.3390/antibiotics10091079. Antibiotics (Basel). 2021. PMID: 34572661 Free PMC article. Review.
Nanotechnology Integration for SARS-CoV-2 Diagnosis and Treatment: An Approach to Preventing Pandemic.
Asdaq SMB, Ikbal AMA, Sahu RK, Bhattacharjee B, Paul T, Deka B, Fattepur S, Widyowati R, Vijaya J, Al Mohaini M, Alsalman AJ, Imran M, Nagaraja S, Nair AB, Attimarad M, Venugopala KN. Asdaq SMB, et al. Among authors: bhattacharjee b. Nanomaterials (Basel). 2021 Jul 16;11(7):1841. doi: 10.3390/nano11071841. Nanomaterials (Basel). 2021. PMID: 34361227 Free PMC article. Review.
The chimera of S1 and N proteins of SARS-CoV-2: can it be a potential vaccine candidate for COVID-19?
Kumar A, Ladha A, Choudhury A, Ikbal AMA, Bhattacharjee B, Das T, Gupta G, Sharma C, Sarbajna A, Mandal SC, Choudhury MD, Ali N, Slama P, Rezaei N, Palit P, Tiwari ON. Kumar A, et al. Among authors: bhattacharjee b. Expert Rev Vaccines. 2022 Aug;21(8):1071-1086. doi: 10.1080/14760584.2022.2081156. Epub 2022 May 31. Expert Rev Vaccines. 2022. PMID: 35604776
Nanoparticle-Based Delivery Systems for Vaccines.
Bezbaruah R, Chavda VP, Nongrang L, Alom S, Deka K, Kalita T, Ali F, Bhattacharjee B, Vora L. Bezbaruah R, et al. Among authors: bhattacharjee b. Vaccines (Basel). 2022 Nov 17;10(11):1946. doi: 10.3390/vaccines10111946. Vaccines (Basel). 2022. PMID: 36423041 Free PMC article. Review.
Nanoemulsions: summary of a decade of research and recent advances.
Chavda VP, Balar PC, Bezbaruah R, Vaghela DA, Rynjah D, Bhattacharjee B, Sugandhi VV, Paiva-Santos AC. Chavda VP, et al. Among authors: bhattacharjee b. Nanomedicine (Lond). 2024 Jan 31. doi: 10.2217/nnm-2023-0199. Online ahead of print. Nanomedicine (Lond). 2024. PMID: 38293801 Review.
The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVID.
Krumholz HM, Sawano M, Bhattacharjee B, Caraballo C, Khera R, Li SX, Herrin J, Coppi A, Holub J, Henriquez Y, Johnson MA, Goddard TB, Rocco E, Hummel AC, Mouslmani MA, Putrino DF, Carr KD, Carvajal-Gonzalez S, Charnas L, De Jesus M, Ziegler FW 3rd, Iwasaki A. Krumholz HM, et al. Among authors: bhattacharjee b. Am J Med. 2024 May 10:S0002-9343(24)00271-7. doi: 10.1016/j.amjmed.2024.04.030. Online ahead of print. Am J Med. 2024. PMID: 38735354
210 results